Nkarta Inc. - מכפיל EV/Sales NKTX

לוגו של חברה ציבורית Nkarta, Inc. (NKTX)

The price-to-sales multiple on GURU.Markets illustrates the valuation dynamics of Nkarta, Inc. (NKTX), where the value 0.00 represents the current figure. The team is effectively developing its cell therapy platform, raising capital to fund scientific research. Innovations in NK cells create the potential for a monopoly and significant pricing power. Anticipation of leukemia treatment data will serve as a catalyst, as current expenditures are already priced in by the market.

Nkarta Corp - שווי חברה להכנסות NKTX (תקופה 23.11.2025 - 20.11.2026)

פילוחי מדדים פיננסיים ומדדי שוק עבור Nkarta (NKTX)

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
הערכת שווי פונדמנטלית של החברה:NKTX (Nkarta Corp)
מוצר סדרתי של nkartatx.com

This indicator determines the market value of the business, adjusted for net debt, in comparison to sales volume. By analyzing historical EV/Sales levels, an investor identifies deviations of the current valuation from average values. The metric aggregates market capitalization and liabilities, dividing them by revenue to eliminate the influence of the financing structure. For Nkarta, Inc. (NKTX), this ratio reflects market expectations regarding the commercialization of NK-therapy. An increase in this metric confirms the confidence of underwriters in the effectiveness of new blood cancer treatment methods.